Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2023-12-07 00:00:00 ET · period of report 2023-12-05 · accession 0001209191-23-057725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-07 | 2023-12-06+ | TXMD | Walker Marlan D | CEO | S - Sale+OE | $2.29 | -19.1K | 67.1K | -22% | -$43.7K |
| D | 2023-12-07 | 2023-12-05 | TXMD | Walker Marlan D | CEO | M - OptEx | $0.00 | +70.0K | 81.6K | +603% | $0 |
| D | 2023-12-07 | 2023-12-05 | TXMD | Walker Marlan D | CEO | M - OptEx | $0.00 | -70.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-07 | S | D | 4,550 | $2.24 | 62,565 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $2.15 through $2.31, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth. |
| 2 | Common | Common Stock | 2023-12-06 | S | D | 14,500 | $2.31 | 67,115 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $2.22 through $2.48, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth. |
| 3 | Common | Common Stock | 2023-12-05 | M | A | 70,000 | $0.00 | 81,615 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2023-12-05 | M | D | 70,000 | $0.00 | 0 | D | $0.00 · — to — | 70,000 Common Stock | (F4) Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on June 30, 2023. |